Intercept Pharmaceuticals IncのEBIT margin
Intercept Pharmaceuticals IncのEBIT marginは何ですか。
Intercept Pharmaceuticals IncのEBIT marginは-16.17%です。
EBIT marginの定義は何ですか。
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
NASDAQのセクタHealth CareにおけるEBIT marginの企業と比べるIntercept Pharmaceuticals Inc
Intercept Pharmaceuticals Incは何をしますか。
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Intercept Pharmaceuticals Incと類似のebit margin
- RigNet IncのEBIT marginは-16.33%です。
- Tuesday MorningのEBIT marginは-16.32%です。
- Peloton Interactive IncのEBIT marginは-16.28%です。
- Zeta GlobalのEBIT marginは-16.26%です。
- Nuix LtdのEBIT marginは-16.25%です。
- Sabre Corp 6.50% Mandatory ConのEBIT marginは-16.24%です。
- Intercept Pharmaceuticals IncのEBIT marginは-16.17%です。
- Shah AlloysのEBIT marginは-16.16%です。
- PeerStreamのEBIT marginは-16.10%です。
- PLBYのEBIT marginは-16.09%です。
- FireEye IncのEBIT marginは-16.02%です。
- Brand Architekts plcのEBIT marginは-15.95%です。
- Storytel AB (publ)のEBIT marginは-15.91%です。